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ABSTRACT
There is limited information in the literature comparing gait speed among
individuals who are in the chronic stages of Parkinson’s disease (PD), stroke and
traumatic brain injury (TBI). The primary aim of this study was to examine the
physical functioning of individuals with these chronic neurological conditions over a
12-month period assessed at baseline (time 1) and six month intervals (time 2, 3).
This observational research study used descriptive statistics and to describe the
physical functioning of individuals with PD, stroke and TBI and was part of a
longitudinal study being conducted over five years to describe communication, dietary
and physical activity behaviors of adults with neurological diagnoses.

Seven

community dwelling adults (n=7) between the ages of 34 and 71 years completed the
evaluations. The tests used to examine physical function included gait speed, repeated
chair stands, short physical performance battery (SPPB), timed up and go (TUG), and
the Physical Activity and Disability Scale (PADS). The results were analyzed for the
cohort and divided into two groups for comparison: PD and acquired brain injury
(ABI). ABI included people with the TBI and stroke diagnoses. Changes in gait
speed were determined using analysis of covariance. A Pearson’s product moment
correlation coefficient was used to determine association between gait speed and
physical function assessments. Statistical significance was set at p < 0.05. Analysis
of covariance (ANCOVA) results showed a statistically significant decrease (i.e.
improvement) in gait speed (p < 0.03) for the ABI group over 12 months. Although
not statistically significant, there was also a decrease in gait speed (p < 0.10) for the
PD group. The ANCOVA results also showed a statistically significant increase (i.e.

decline) in the TUG test time of 3.33 seconds (p = 0.054) for the ABI group and
increases in time for the PD group and cohort. Baseline gait speed for all participants
correlated with the total SPPB score r = -0.97, p = 0.001) and the TUG test (r = 0.97, p
= 0.001). Time 3 gait speed for all participants also correlated with the PADS score (r
= -0.79, p = 0.06) in addition to the SPPB score (r = -0.87, p < 0.01) and TUG test (r =
0.96, p < 0.01). There was a statistically significant decrease in gait speed of adults
with ABI measured three times in 12 months.

Secondary findings include the

significant decline in mobility in adults with ABI measured over 12 months. The
significant relationship between gait speed and the physical function, mobility and
physical activity scores was also a secondary finding. Future studies should consider
interventions aimed at improving physical activity and fall and balance self-efficacy to
explore the impact on gait speed in chronic neurological conditions.

Future

longitudinal research should also be conducted with a larger sample size and broader
range of chronic neurological conditions to allow generalization of the study findings.
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ABSTRACT
Background: There is limited information assessing gait speed over time in the
chronic stages of Parkinson’s disease (PD) and acquired brain injury (ABI).
Hypothesis: There will be no change in gait speed in adults with chronic neurological
conditions measured three times over 12 months.
Methods: An observational research design was used to examine physical functioning
in seven participants over 12 months. Physical status was assessed using the short
physical performance battery (SPPB), timed up and go (TUG), and Physical Activity
and Disability Scale (PADS). Cognitive function was examined using the Repeatable
Battery for the Assessment of Neuropsychological Status (RBANS). Data were
analyzed using descriptive statistics, analysis of covariance, and Pearson’s correlation
coefficients.
Results: ANCOVA results showed a decrease in gait speed within the ABI group (p
< 0.03) and within the PD group (p < 0.10) along with an increase in the TUG time of
3.33 seconds (p = 0.054) for the ABI group and increases in time for the PD group and
cohort. Gait speed at 12 months correlated with the PADS score (r = -0.79, p = 0.06),
SPPB score (r = -0.87, p < 0.01) and TUG test (r = 0.96, p < 0.01) for the cohort.
Conclusions: There was a statistically significant improvement in gait speed of adults
with ABI measured over 12 months. Secondary findings include 1) a significant
decline in mobility in adults with ABI and 2) the significant relationship between gait
speed and the physical function, mobility and physical activity scores.
Keywords. Parkinson’s disease, traumatic brain injury, stroke, gait speed, physical
function
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INTRODUCTION
Traumatic brain injury (TBI) and stroke affect 1.7 million and 795,000 Americans
in the United States (US) each year respectively1,2. At the same time, one million
people in the US are living with Parkinson’s disease3. Parkinson’s disease (PD), TBI
and stroke can result in disabilities that include decreased ability to communicate,
difficulty maintaining a healthy diet, and reduced levels of physical activity and
physical function. The TBI and stroke diagnoses are both considered acquired brain
injury (ABI).
Individuals with ABI and PD are particularly vulnerable to the damaging effects
of physical inactivity and face declines in balance, coordination, strength, mobility and
overall quality of life4. Gait speed, coined the sixth vital sign, has been suggested to
correlate with functional ability and balance confidence and aids in determining
rehabilitation potential and fall risk5. Additionally, gait speed improvement has been
linked to enhanced quality of life5,6 and is critical to maintaining community
ambulation or independent mobility outside the home7.
There is limited information in the literature about gait speed in individuals who
are in the chronic stages of PD and ABI8. There is even less information that jointly
examines gait speed in persons with PD or ABI. Therefore, the primary aim of the
study was to examine the physical functioning of individuals with chronic
neurological conditions of stroke and ABI over a 12-month period assessed at six
month intervals. Specifically, the null hypothesis was that there will be no change in
gait speed of adults with chronic neurological conditions measured three times over 12
months. Independent predictors of changes in gait speed including the short physical
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performance battery (SPPB) total score, repeated chair stands, timed up and go (TUG)
test, Physical Activity and Disability Scale (PADS) score, and Repeatable Battery for
the Assessment of Neuropsychological Status (RBANS) delayed memory index were
also explored.
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METHODOLOGY
Study Design
This observational research study used surveys and quantitative evaluations to
assess the physical functioning of individuals with PD and ABI. The study lasted 12
months and consisted of three evaluations: baseline, time 2, and time 3. The baseline
measures were collected when the participants joined the study. Time 2 measures
were collected at six months and time 3 measures were collected at 12 months. The
study was part of an Institutional Review Board (IRB) approved longitudinal study at
the University of Rhode Island being conducted over five years to describe
communication, dietary and physical activity behaviors of adults with neurological
diagnoses (Longitudinal Study of Communication, Nutrition and Physical Activity,
IRB HU1314-006).

Participants
The longitudinal study participants were required to be 1) diagnosed with PD,
TBI or stroke, 2) determined to be medically stable by a neurologist, 3) between the
ages of 18 and 85 years, and 4) sign an informed consent form. They were recruited
equally in an attempt to represent the demographics of Rhode Island. Rolling
admission was accomplished through word of mouth and by sending brochures to
local physicians, hospitals and support groups. Of the 15 participants currently in the
study, seven completed three evaluations in the 12-month period of this study.
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Outcome Measures
The independent variables in this study were the neurological conditions. Gait
speed, a component of the SPPB, was the primary outcome measure. Changes in other
measures of physical function including the SPPB score, repeated chair stands, and
TUG test were examined to determine if there was a relationship or association with
changes in gait speed. Dependent variables including the PADS score and RBANS
delayed memory index were also analyzed to determine if there is a relationship with
changes in gait speed. Following is a description of the instruments and techniques
used to collect these data along with the anthropometric data.
Physical Functioning Assessment. The SPPB instrument is widely used to assess
lower extremity function and takes fewer than ten minutes to complete. It includes
using three low participant-burden activities to assess participant’s physical
functioning: gait speed, standing balance, and time to rise from a chair and return to
the seated position. The score range for each subtest is zero to four points with a
maximum cumulative score of 12 points9, 10. Each test was timed using a hand held
stopwatch.
Gait speed was measured by having the participants walk at their usual pace on a
measured and taped course. The distance for this study was four meters and the
participants began and ended the test in the standing position. Additional unobstructed
space was be marked at the end of the walking course and participants were instructed
to continue walking through the finish line to prevent deceleration in pace. The test
was repeated and the faster of the two tests was used in the data analysis9.
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Participants performed side-by-side, semi-tandem (heel of one foot by big toe of
other foot) and tandem (feet aligned heel to toe) foot positions for the standing balance
tests. They were assisted to the standing position as needed and timed when they were
standing independently. The timing ended at 10 seconds or earlier if the participant
lost balance by moving their feet or grasping for support9.
Five-time repeated chair stands were performed to test lower extremity strength
and endurance. A chair was placed against the wall. Participants were instructed to
fold their arms over their chests and attempt one stand. If successful, participants
were asked to stand and sit as quickly as possible without the use of their arms for five
repetitions. Participants were timed from the point when they arose from the chair,
stood five times and returned to the seated position9.
A TUG test was also conducted. The TUG test is a valid predictor of falls and
mobility and measures the time in seconds required for an individual to rise from a
chair, walk a prescribed distance, return and sit down in the chair11. The TUG test
used in this study was conducted according to a standardized protocol where
participants were asked to rise from a chair, walk forward four meters at their usual
walking pace, turn 180 degrees around a cone, walk four meters back to the chair, and
finally sit down. The test was repeated and the better of the two tests was used in the
data analysis. The test was timed using a hand held stopwatch.
Physical Activity and Disability Scale. The PADS, a self-reported survey,
provides a reliable and valid measure of physical activity for persons with disabilities
or chronic health conditions and has been reported to detect intervention related
changes in physical activity12. It is composed of six subscales: exercise, leisure time,
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physical activity, general activity, therapy, employment/school and wheelchair users
and takes approximately 20 minutes to complete. The survey is known to discriminate
between different levels of activity and participants report that it enables them to give
an accurate description of their level of exercise4. The participants were interviewed
to collect the data for the survey. The scores were calculated using a standardized
scoring tool.
Repeatable Battery for the Assessment of Neuropsychological Status (RBANS).
The RBANS consists of 12 subtests and takes less than 30 minutes to administer. It is
used to measure and yields index scores in immediate and delayed memory, language,
attention and visuospatial/ constructional abilities. The results can be used to assess
cognitive function in individuals from 20-89 years in age13. This study explored
whether the delayed memory index is an independent predictor of gait speed in
individuals with chronic neurologic conditions. The delayed memory index includes
four subsets (list recall, list recognition, story recall, and figure recall) that measure
recall and recognition13.
Anthropometric measures. The anthropometric measures included height, weight,
body mass index (BMI) and body composition. Height and weight were measured
using a balance beam scale (Detecto, Webb City, MO). The scale was zeroed prior to
testing and participants were measured standing erect with their backs to the height
measuring rod and in bare feet. The measurements were entered into the formula
kilograms of body weight divided by height in meters squared (kg/m2) to determine
BMI.
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Body composition was measured using a foot to foot bioelectrical impedance
analysis (BIA) device (Tanita BC-534 Inner Scan Body Composition Monitor, Tanita
Corporation of America, Inc, Arlington Heights, IL). The BIA device is a portable
battery powered foot-to-foot BIA device that resembles a bathroom scale. It uses a
very low electrical current to estimate percent body fat14.

Participants were measured

standing erect with bare feet on the analyzer foot pads. The individual’s age, gender,
height, weight, and activity level was entered into the analyzer prior to standing on the
foot pads.

Statistical Analysis
A sample size was calculated using SAS statistical software (SAS Institute Inc.,
version 9.2, Cary, NC) and the potential change in gait speed and standard deviation
were based on previous research15. The sample size calculations were founded on an
alpha of 0.05, a power of 80%, expected within group difference of 0.18 m/s for gait
speed, and a within group standard deviation of 0.12 m/s. Based on the criteria, the
one group sample size was approximately six participants.
Data analyses were conducted using SAS statistical software (SAS Institute Inc.,
version 9.2, Cary, NC) and Microsoft Excel (Microsoft Corporation, version 2013,
Redmond, WA). Mean values for demographic and descriptive characteristics were
calculated for all participants and the PD and ABI groups and are represented as
continuous variables. Normality of the data was determined using the Shapiro-Wilk
test. An outlier analysis was performed for gait speed using the mean plus or minus
three standard deviations. A repeated measures analysis of covariance (ANCOVA)
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was used to examine changes in gait speed for the cohort and the between the PD and
ABI groups over the course of the study. The covariate was the baseline measure for
each group. Statistical significance was set at p < 0.05. Additionally, correlations
were conducted to quantify the relationship between gait speeds and the SPPB, TUG,
PADS and RBANS delayed memory index scores. A Pearson's product moment
correlation coefficient was calculated to evaluate the relationships16.
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RESULTS
The results were reviewed for the cohort and divided into two groups for
comparison: PD and ABI. A Shapiro-Wilk test supported the normality of the data at
baseline (p = 0.28) and time 3 (p = 0.30). Demographic characteristics,
anthropometric measures and indicators of physical functioning, physical activity and
cognitive function for each group are summarized in Table 1. The participants
included six males and one female and were between the ages of 34 and 71 years. The
mean age for the PD group was 67.5 years and the ABI group was 43 years. All
participants were community dwelling adults living with PD or ABI for greater than
three years. Four participants were diagnosed with PD and three were diagnosed with
an ABI. Of the three ABI participants, one was diagnosed with stroke, one with TBI
and one was diagnosed with both stroke and TBI. There were statistically significant
differences (p < 0.05) between the PD and ABI groups in age, SPPB total, gait speed
and the TUG test.
Table 2 displays the changes that occurred from the baseline to the time 3
measurements in the cohort, PD and ABI groups. Each of the groups experienced a
decrease in weight, body fat, BMI and gait speed. There was also an increase in the
TUG time and the PADS score for each group. The total SPPB score increased for the
ABI and decreased for the cohort and PD groups. Contributing to this score was the
decrease in the chair stand time for the ABI group and increase in the cohort and PD
groups. The RBANS delayed memory index decreased in the PD group and increased
in the cohort and ABI group.
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The ANCOVA results for the gait speed changes are displayed in Table 3. The
results showed a statistically significant decrease (i.e. improvement) in gait speed (p =
0.032) for the ABI group. Although not statistically significant, there was also a
decrease in gait speed for the PD group (p = 0.099) and cohort. The difference
between the groups was not significant.
The ANCOVA results displayed in Table 4 also showed a statistically significant
increase (i.e. decline) in the TUG test time of 3.33 seconds (p = 0.054) for the ABI
group and increases in time for the PD group and cohort. The difference between the
groups was not significant.
Baseline gait speed for all participants correlated with the total SPPB score (r = 0.97, p < 0.001) and the TUG test (r = 0.97, p < 0.001). No significant correlation
was found between baseline gait speed and the chair stands, PADS score, or RBANS
Delayed Memory Index. Time 3 gait speed for all participants also correlated with the
PADS score (r = -0.79, p = 0.06) in addition to the SPPB score (r = -0.87, p < 0.01)
and TUG test (r = 0.96, p < 0.01).
Baseline, time 2 and time 3 performance measures for each participant are
reported in Table 7. Each participant attended the three evaluations; however, two
participants were not able to complete the repeated chair stands, one participant was
not able to complete the TUG test, and one participant did not complete the PADS
instrument.
Physical functioning (SPPB)
Baseline SPPB scores ranged from 5 - 11. At time 3, three of the participants
increased their score, one remained the same and three participants had a lower score.
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The total score was lowest for the two participants that could not complete the
repeated chair stands.
Gait Speed
Baseline gait speeds for the four meter test ranged from 4.16 to 9.68 seconds or
0.41 to 0.96 m/s. All of the participants demonstrated an increase in the m/s; however,
six of the seven participants demonstrated a meaningful change that ranged from 0.11
to 0.48 m/s.
Lower Extremity Performance (Repeated Chair Stands)
Two participants were unable to complete the repeated chair stands and two
participants increased the time required to complete the test suggesting a decline in
lower extremity performance. Three of the participants decreased the time that they
required to complete the repeated chair stands.
Mobility (TUG Test)
Baseline scores for the TUG test ranged from 8.16 seconds to 18.31 seconds or
1.02 to 2.29 seconds per meter respectively. One participant was unable to complete
the test at time 3, one participant experienced a minimal decrease in score and the
remaining five participants demonstrated an increase in the time needed to complete
the test.
Physical Activity (PADS)
Four of the seven participants improved from their baseline PADS score during
the course of the study. One participant did not complete the survey at time 3;
however, the participant did show improvement at time 2. Baseline scores ranged

13

from 26.4 to 310.9. Scores at time 3 ranged from -21 to 302.2 with a variable change
of -6 to 705%.
Recall and Recognition (RBANS Delayed Memory Index)
The RBANS scores ranged from 40 to 102 at baseline with a variable change of 8 to 21% at the time 3 evaluation. No correlation was observed between gait speed
and the delayed memory index in the cohort.
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DISCUSSION
To our knowledge, this is the first study to compare gait speed in adults with PD
and ABI in the chronic stages of recovery. The primary finding of the study rejects
the null hypothesis that there will be no change in gait speed of adults with chronic
neurological conditions measured three times in 12 months. The results indicated that
there was a decrease (i.e. improvement) in gait speed in adults with chronic
neurological conditions and statistically significant improvements in participants with
ABI measured three times in 12 months.
The time required to complete the 4-m gait speed test improved for the ABI group
by 2.53 seconds (p = 0.03) and for the PD group by 0.85 seconds (p = 0.10). Although
not statistically significant, the time also improved for the cohort by 1.57 seconds (p =
0.38). The improvement in walking speed was 0.17 m/s for the PD group, 0.26 m/s
for the ABI group and 0.23 m/s for the cohort. The improvements exceed the
minimally meaningful change for the 4-m gait speed test has been reported by Kwon
et al. as 0.03-0.05 m/s17 suggesting that the improvements experienced by the study
cohort may have important implications in community ambulation.
Gait speed has been reported to be the most efficient predictor of household and
community ambulation, a significant determinant of community ambulation, and a
powerful indicator of function and prognosis post-stroke18-20. The gait speed cut-off
points for community ambulation have been reported in several articles and range
from 0.66 m/s for community ambulation19 to 0.8 m/s for full community
ambulation20. The gait speed for the each of the groups exceeded the cut-off point of
0.66 m/s and the threshold for full community ambulation (Cohort 0.90 m/s, PD 1.0
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m/s, ABI 0.8 m/s) at the time 3 evaluation. The individual scores ranged from 0.66
m/s to 1.08 m/s for the participants with PD and 0.63 to 0.92 m/s for the participants
with ABI.
Although gait speed improved for all participants, the time required to complete
the mobility test increased resulting in a performance decline for each of the groups
and participants. The TUG times in m/s for the cohort, PD and ABI groups equated to
0.55 m/s, 0.76 m/s, and 0.43 m/s, respectively. This may have resulted from the 180
degree turn in the TUG and deficits in balance, coordination and self-efficacy that are
experienced by individuals with chronic neurological conditions. The declines are
consistent with a longitudinal study by van de Port et al.21 that suggested that mobility
is not stable, but time dependent with approximately 20 percent of the participants
experiencing decreased mobility from one to three years post-stroke21. They are also
similar to a study where individuals with chronic TBI were found to exceed the MDC
for walking speed with smaller gains in the TUG test. Gains that were maintained at
the three month post intervention were attributed to improvements in gait speed,
mobility, balance and fall self-efficacy22.
The mean ages of the PD and ABI groups were also considered as confounding
variables on the gait speed and mobility results. The mean age for the PD group was
24.5 years greater than the mean age of the ABI group. Thus, this could have had an
effect on these results as the aging process is accompanied by sarcopenia or a gradual
loss of skeletal muscle mass and function that typically begins after age 30 that is
associated with worsened physical functioning23. In a three year study by Trombetti et
al.24, participants with age-associated declines in muscle mass, strength, power and
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physical performance were found to have decreased SPPB scores and increased walk
times24. The PD group (mean age 67.5, SD 3.8) had higher scores on the SPPB and
walked faster than the ABI group (mean age 43, SD 13) over the course of the study.
However, the ABI group exhibited greater improvements in their SPPB scores and
walking speed at time 3 possibly due to their younger age.
Major findings of the study also included the statistically significant relationship
identified between gait speed at baseline and time 3, and the total SPPB score and
TUG test for all participants. At time 3, there was also significant correlation PADS
score. The PADS has been reported to detect changes in physical activity in persons
with disabilities and chronic health conditions12. There was an increase in the PADS
score for each group. Although this study did not involve an intervention, the majority
of the participants were engaged in physical therapy, occupational therapy or physical
training and an increase in physical activity was reported via the PADS interview for
five of the seven participants. The increase in physical activity may have contributed
to the previously mentioned improvement in gait speed times, but this is merely
speculative.
A study by Duff et al.25 reported significant partial correlations (p < 0.01)
controlling for age, gender and education between gait times and the RBANS total
score and component indexes (total r = -0.25, immediate memory r = -0.20,
visuospatial/constructional r = -0.18, language r = -0.12, attention r = -0.21, delayed
memory r = -0.15)25. A recent study reported that poorer short term memory assessed
using a 10 word recall test (immediate and delayed recall) was associated with slower
gait speed in community dwelling individuals 50 years and older26. However, no
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correlation was observed between gait speed and the RBANS delayed memory index
in the cohort.
The SPPB was established by Guralnik et al. as a disability measure for older
adults9. In 2010, Vazzana et al.27 defined impaired mobility as a SPPB score of less
than 1027. The component tests provide an indication of physical function including
gait speed, balance and lower extremity performance. All total scores for the cohort
and PD and ABI groups were 10 or less suggesting impaired mobility. The scores
ranged from 8.0 to 8.8 at time 3 with the total SPPB score increasing for the ABI
group and decreasing for the cohort and PD groups. Contributing to the scores was
the improvement in the repeated chair stand time for the ABI group and decline in the
cohort and PD groups. A minimally meaningful change for the SPPB has been
reported by Kwon et al. as 0.3 – 0.8 points17. The total SPPB score improved
clinically for the ABI group by 1.3 points for a mean total score of 8.0. The score
declined for the PD group by 1.2 points and the cohort by 0.2 points for mean total
scores of 8.8 and 8.4, respectively.
The longitudinal findings of this study are an improvement to the existing
knowledge and will contribute to identifying the natural progression of disability in
the PD and ABI populations. Limited longitudinal studies are available in the
literature that evaluated physical functioning in chronic neurological conditions and
those found primarily concern the stroke population. For example, a longitudinal
study by van de Port et al.21 focused on deterioration of mobility from one to three
years post-stroke used a self-reported mobility index consisting of 14 questions and
one observation to assess mobility21. The present study used objective performance
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measures to assess gait and mobility. Peters et al.22, studied balance, mobility and gait
speed in individuals with chronic TBI. The study involved task specific training to
address balance, gait, strength and coordination. Evaluations were performed at
baseline, after 10 exercise sessions and 20 exercise sessions. A follow up evaluation
was performed at three months and the gait speed and mobility gains were maintained
by the participants22; however, no further evaluations were conducted.
Limitations of the study included the small sample size, multiple examiners, the
participants being exposed to different medical interventions during the study
(physical therapy, occupational therapy, physical training) and the effects of repeated
testing. The small sample size limited the ability to detect statistical significance and
the generalizability of the results to individuals with PD, TBI and stroke. Although
there were multiple examiners, a study strength included using defined protocols and
trained observers for each of the tests. For the self-reported physical activity survey,
interviews were used to obtain the information and the examiner was able to rephrase
questions or ask additional questions to clarify responses. As part of this survey,
information was also collected on the time each participant spent in therapy or
physical training and the activities that resulted in an increased PADS score. Repeated
testing could be also be seen as a threat to internal validity as individuals become
familiar with the test items and perform better on subsequent tests; however, periodic
evaluations over time were also a strength of the 12-month study28.
The key barriers to adopting physical activity include self-efficacy; fear of falling;
and disability, balance and environmental concerns29-32. Although not examined in
this study, evaluating these behaviors in future research may provide additional insight
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into the barriers that result in reduced levels of physical activity in the PD, TBI and
stroke populations. Additionally, future research should expand recruitment across the
three conditions, to compare differences between PD, TBI and stroke, rather than just
PD and ABI. Future longitudinal studies should consider adding an intervention
designed to ameliorate gait speed, mobility and self-efficacy and monitor the long
term changes in physical function.
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CONCLUSIONS
In summary, this is the first study to compare gait speed in adults with PD and
ABI in the chronic stages of recovery. The results indicated that there was a
statistically significant improvement in gait speed of adults with ABI over the 12month period studied. Secondary findings included the significant decline in mobility
in adults with ABI measured three times in 12 months and the relationship between
gait speed and the physical function, mobility and physical activity scores. Future
studies should consider interventions aimed at improving physical activity and fall and
balance self-efficacy to explore the impact on gait speed in chronic neurological
conditions. Future longitudinal research should be conducted with a larger sample
size and broader range of chronic neurological conditions to verify the study findings.
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TABLES
Table 1: Baseline Characteristics of the Cohort and PD and ABI groups.

Age (years)
Months Elapsed

All (n=7)

PD (n=4)

ABI (n=3)

P-value

57.0 (15)

67.5 (3.8)

43.0 (13)

0.015

128.4 (80.7)

80.8 (57)

192 (63.5)

0.059
0.429

Gender
Men

6

4

2

Women

1

0

1

Height (cm)

173.7 (7.1)

172.4 (6.6)

175.5 (8.8)

0.615

Weight (kg)

81.8 (11.4)

80.6 (11.9)

83.4 (13.0)

0.783

Body Fat (%)

28.0 (5.6)

26.7 (3.4)

30.7 (10.0)

0.466

BMI (kg/m2)

27.0 (2.1)

27 (2.7)

26.9 (1.6)

0.960

SPPB (total points)
SPPB Gait Speed
(seconds)
SPPB Chair Stand
(seconds)
TUG Test (seconds)

8.6 (2.1)

10 (.82)

6.7 (1.5)

0.013

6.0 (2.0)

4.8 (.88)

7.6 (2.0)

0.050

13.2 (2.0)

13.4 (2.44)

12.9 (0.9)

0.812

12.4 (3.7)

10.1 (1.8)
137.6
(118.2)

15.4 (3.5)

0.045

90.2 (64.6)

0.563

72.7 (25.8)

0.922

PADS score
RBANS Delayed
Memory score

117.3 (95.0)
74 (27.0)

75 (31.9)

All data are expressed as means with (standard deviations). Exception – gender
P-value was calculated using an unpaired t-test and represents the between PD and
ABI group differences. P-value for gender was calculated using a Fisher’s Exact Test.
SPPB (4m walk, balance, repeated chair stands) - physical function
SPPB Gait Speed – 4 meter walk measured in seconds
SPPB Chair Stand - repeated chair stands measured in seconds
TUG Test – 8 meter mobility test measured in seconds
PADS score - physical activity level
RBANS delayed memory index (list recall, list recognition, story recall, and figure
recall) - recall and recognition
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Table 2: Baseline, Time 2, Time 3 Data and Change in the Cohort and PD and ABI
Groups
Dependent Variable

All (n=7)

PD (n=4)

ABI (n=3)

P-value

Baseline

8.6

10.0

6.7

0.013

Time 2

8.7

9.8

7.3

SPPB (total points)

Time 3

8.4

8.8

8.0

Change

-2%

-12%

19%

Baseline

6.0

4.8

7.6

Time 2

4.8

3.6

6.3

Time 3

4.5

4.0

5.1

Change

-25%

-17%

-33%

Baseline

13.2

13.4

12.9

Time 2

14.6

12.5

16.6

Time 3

13.3

14.2

12.0

Change

1%

6%

-7%

Baseline

12.4

10.1

15.4

Time 2

14.8

11.0

19.8

Time 3

14.6

10.5

18.7

Change

18%

4%

21%

Baseline

117.3

137.6

90.2

Time 2

120.8

129.3

109.6

Time 3

168.6

140.0

197.1

Change

44%

2%

119%

Baseline

74.0

75.0

72.7

Time 2

81.9

87.3

74.7

Time 3

76.3

74.0

79.3

Change

3%

-1%

9%

0.786

SPPB Gait Speed (seconds)
0.050
0.325

SPPB Chair Stand (seconds)
0.812
0.484

TUG Test (seconds)
0.045
0.013

PADS (total points)
0.563
0.636

RBANS Delayed Memory Index
0.922
0.828

All outcome variable data are expressed as means. P-value was calculated using an
unpaired t-test and represents the between PD and ABI group differences.
SPPB (4m walk, balance, repeated chair stands) - physical function
SPPB Gait Speed – 4 meter walk measured in seconds
SPPB Chair Stand - repeated chair stands measured in seconds
TUG Test – 8 meter mobility test measured in seconds
PADS score - physical activity level
RBANS delayed memory index (list recall, list recognition, story recall, and figure
recall) - recall and recognition
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Table 3: Gait Speed Time Changes Within Cohort, PD and ABI Groups and Between
PD and ABI Groups
Gait Speed (seconds)

Mean Change

Std Dev

P-value

Within All

-1.57

1.19

0.384

Within PD

-0.85

0.76

0.100

Within ABI

-2.53

0.97

0.032*
0.384

Between PD & ABI
*Significant at p < 0.05
SPPB Gait Speed – 4m walk measured in seconds

Table 4: TUG Changes Within Cohort, PD and ABI Groups and Between PD and
ABI Groups
TUG (seconds)

Mean Change

Std Dev

P-value

Within All

2.21

1.91

0.190

Within PD

1.10

1.01

0.876

Within ABI

3.33

2.09

0.054*
0.190

Between PD & ABI
*Significant at p = 0.05
TUG Test - 8m mobility test measured in seconds
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Table 5: Baseline, Time 2, Time 3 Data and Change for each Participant
Outcome Measures Baseline

Time 2

Time 3

Change

SPPB Score
Participant 1

9

7

4

-56%

Participant 2

10

10

9

-10%

Participant 3

10

10

11

10%

Participant 4

11

12

11

0%

Participant 5

8

8

9

13%

Participant 6

7

9

11

57%

Participant 7

5

5

4

-20%

Participant 1

6.09

4.08

6.05

-1%

Participant 2

4.3

2.87

3.14

-27%

Participant 3

4.78

3.34

3.04

-36%

Participant 4

4.16

4.22

3.72

-11%

Participant 5

5.81

5.19

4.37

-25%

Participant 6

7.31

5.83

4.48

-39%

Participant 7

9.68

7.89

6.37

-34%

Participant 1

10.47

N/A

N/A

Participant 2

14.31

14.93

18.19

27%

Participant 3

16.16

12.09

12.27

-24%

Participant 4

12.46

10.46

12

-4%

Participant 5

13.5

10.16

11.16

-17%

Participant 6

12.25

13.41

12.87

5%

Participant 7

N/A

26.29

N/A

Participant 1

12.22

13.48

N/A

Participant 2

8.16

9.71

9.93

22%

Participant 3

10.79

9.91

10.72

-1%

Participant 4

9.16

11.06

10.75

17%

Gait Speed

SPPB Chair Stands

TUG test
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Participant 5

11.5

15.03

16.3

42%

Participant 6

16.43

17.12

17.37

6%

Participant 7

18.31

27.36

22.56

23%

Participant 1

46.5

22.8

-21

-145%

Participant 2

310.9

176.6

291.9

-6%

Participant 3

86

161.7

N/A

Participant 4

107.1

156

149.1

39%

Participant 5

155.6

137.6

302.2

94%

Participant 6

26.4

165.5

212.4

705%

Participant 7

88.5

25.6

76.7

-13%

PADS Score

RBANS Delayed Memory Index
Participant 1

40

60

44

10%

Participant 2

102

112

106

4%

Participant 3

56

75

52

-7%

Participant 4

102

102

94

-8%

Participant 5

94

97

97

3%

Participant 6
Participant 7

44
80

44
83

44
97

0%
21%

SPPB (4m walk, balance, repeated chair stands) - physical function
SPPB Gait Speed – 4 meter walk measured in seconds
SPPB Chair Stand - repeated chair stands measured in seconds
TUG Test – 8 meter mobility test measured in seconds
PADS score - physical activity level
RBANS delayed memory index (list recall, list recognition, story recall, and figure
recall) - recall and recognition
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APPENDICES
Appendix A: Review of the Literature
Introduction
Traumatic brain injury (TBI) and stroke affect 1.7 million and 795,000 Americans
each year respectively1, 2. At the same time, approximately one million people in the
United States are living with Parkinson’s disease3. Parkinson’s disease (PD), TBI and
stroke disabilities include decreased ability to communicate, difficulty maintaining a
healthy diet, and reduced levels of physical activity and physical function. However,
limited longitudinal data exist on these behaviors beyond the acute phases of recovery
and in the chronic phases of rehabilitation4.
The purpose of this literature review is to describe the epidemiology of PD, TBI
and stroke and their association with physical function, specifically gait speed, in the
chronic stages of the diseases. The report will also review current research that
examined gait speed as a measure of physical performance and function in these
populations.

Parkinson’s Disease
Parkinson's disease is a chronic and progressive movement disorder that worsens
over time and affects two percent of individuals age 60 years and older5. Older males
have a higher risk of developing PD6. The prevalence and incidence increases with
age and peaks after 80 years of age. The male to female ratio for disease is
approximately 3:27. Family history has also been found to be a strong predictor5.
Ethnicity is a risk factor with Hispanics having the highest risk followed by non-
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Hispanic whites, Asians and Blacks7. With the aging of the population, a 50 percent
increase in adults with the disease is expected by 20307.
The cause of PD is not completely understood and there is presently no cure3.
The condition likely results from the attrition of dopamine producing neurons that
regulate motor function, genetics or environmental exposures5. Loss of dopaminergic
neurons within the substantia nigra pars compacta (SNpc) has been noted to be the key
pathological feature in PD7. There is a 9-13 percent loss of these neurons for every 10
years of life and 70-80 percent of these neurons are lost before the first symptoms
appear5. Lewy pathology is another characteristic of PD. Lewy bodies in surviving
SNpc neurons appear to have causal roles in neuronal loss in PD. Neuroinflammation
is another characteristic; however, the whether neuroinflammation promotes or
protects from neurodegeneration has yet to be determined. Genetics also plays a role
in PD factors and multiple genes have associated with PD based on mutations
identified as causes of familial PD7.
Precipitating factors include a history of mild to moderate head injury, betablocker use and exposure to toxicants including the herbicide paraquat6, 7. Factors
associated with a decreased risk for developing the disease include physical activity,
non-steroidal anti-inflammatory drug use, calcium channel blocker use, alcohol
consumption and protective genetic factors. Smoking and coffee consumption have
also been reported to be lower in adults who develop PD. Smoking may be reduced
due to the decreased response to nicotine during early PD6, 7.
Individuals with PD experience motor symptoms including resting tremors,
rigidity, hypokinesia, bradykinesia and postural instability. Secondary symptoms
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include stooped posture; impaired coordination; decreased cognition, attention,
executive function, memory; dementia; sleep disorders; sensory changes; speech
problems; and difficulty swallowing3. Progression of PD is characterized by
worsening of the motor symptoms. In the late stages of the disease, treatment resistant
motor and non-motor characteristics including postural instability, freezing of gait,
falls, dysphagia and speech dysfunction become prominent. Eighty percent of adults
with the disease are reported to have freezing of gait and falls and 50 percent choking
after 17 years of disease. Dementia is reported in 83 percent of adults after 20 years of
disease duration7. Older age at the onset the disease has been associated with faster
rates of motor progression and mortality. Early onset may increase the risk for
dystonia6.
Clinical diagnosis of PD is based on the presence of parkinsonian motor features
and absence of other diseases that cause Parkinsonism. Diagnostic tests for definitive
diagnosis in the early stages of the disease do not exist. The presence of moderate to
severe SNpc degeneration and Lewy pathology at the post mortem exam is the current
gold standard for diagnosis7.
Therapies for PD treat the symptoms and not the underlying causes of PD. The
goals of pharmacological treatments are to improve function and quality of life and
should be started at diagnosis. Treatment for motor symptoms include dopamine
replacement and dopamine agonists. The medications include levodopa, dopamine
agonists, monoamine oxidase type B inhibitors and amantadine. Non-motor
treatments are condition specific and are often have a limited response7.
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Deep brain stimulation is also effective in treating tremors and motor symptoms
moderate to severe PD. This surgical treatment is implicated in cases where motor
symptoms respond to levodopa but motor fluctuations and dyskinesia become
disabling. The treatment can also improve non-motor fluctuations in sleep-related
symptoms and behavioral abnormalities and is usually performed 10-13 years after
diagnosis7.
Treatments including the introduction of dopamine agonist and dopamine
replacement therapy are frequently based on change of functional status. Changes in
functional status and disability are commonly assessed through surveys or physical
functioning assessment8. Gait impairment is a common finding in individuals
diagnosed with PD and is characterized by decreased gait speed, shortened steps,
stooped posture and reduced arm swing9, 10. It is a common focus of pharmacological,
behavioral and surgical intervention and gait speed has been singled out as a measure
due to its relevance to community independence and predictive value for important
health outcomes and mortality10.
Haas et al.10 studied the minimal clinically important difference (MCID) for gait
speed in adults in various stages of PD. Data for the study were collected on 324
individuals currently receiving pharmacological treatment for their PD symptoms.
Sixty seven percent of the participants were male. The average age of the cohort was
68 with a standard deviation (SD) of 10. The time since diagnosis averaged 8 years
(SD 6). The methods used to measure gait speed included the 5.8 x 0.9 meter (m)
GAITRite instrument walkway system. The participants performed four walking trials
at a comfortable pace. The course started 1.5-m before the walkway and ended 1.5-m
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after the walkway to minimize acceleration and deceleration effects. None of the
participants used assistive devices and in the event of a freezing episode additional
walks were performed. Cross sectional analysis of the clinically important differences
for gait speed was completed using disability (Schwab and England Activities of Daily
Living Scale), disease stage (Modified Hoehn and Yahr Scale (H&Y)) and severity
(Unified Parkinson’s Disease Rating Scale (UPDRS)) distribution and anchor based
approaches. The distribution measures relied on the distribution of scores as in the
minimal detectable change (MDC) and effect size and anchor approaches relied on
responsiveness to independent measures. The magnitude of effect for the distribution
approach was based on the Cohen effect size recommendations of 0.2 as small, 0.5 as
moderate and 0.8 as large. The average gait speed was 0.98 m/s with a range of 0.22 –
1.73 m/s (SD 0.27 m/s). Using distribution based analysis, the MCID ranged from
0.05 m/s to 0.22 m/s. Whereas, the MCID ranged from 0.02 m/s to 0.15 m/s through
the use of anchor based metrics. A key limitation of the study was using only short,
straight walking distance that is not reflective of community ambulation. The results
of the study will serve as a tool for evaluating intervention effectiveness and
benchmarking treatment effects for individuals with PD on medication10.
A study by Tanji et al.8 compared physical performance measures for their ability
to discriminate between levels of disability and disease severity in PD. The cohort
included 79 individuals age 65.5 (SD 10.6) years with PD. The participants were
tested with seven physical performance measures including the Physical Performance
Test (PPT), modified PPT (mPPT), SPPB, Performance Test of Activities of Daily
Living (PADL), Berg Balance Scale (BBS), TUG test and Functional Reach (FR).
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Disability was assessed using the Older Americans Resource and Services and
Disability Subscale (OARS) and severity was assessed using the UPDRS. The
participants were divided into quartiles based on their OARS and UPDRS ratings. All
seven measures discriminated across the quartiles of the total severity ratings (PPT,
mPPT, BBS, TUG, FR: p < 0.01; SPPB, PADL: p < 0.05) and four measures
discriminated across the disability ratings (PPT, mPPT, BBS, TUG: p < 0.05). All of
the measures were more strongly associated with severity than disability and declined
as the participants moved to worsening stages of severity. The SPPB, BBS and TUG
correlated significantly with both disability (SPPB r = 0.41 – 0.56, p < 0.05; BBS r =
0.55 – 0.60, p < 0.01; TUG r = 0.37 – 0.58, p < 0.05) and severity (SPPB r = 0.56 –
0.59, p < 0.01; BBS r = 0.59 – 0.74, p < 0.01; TUG r = 0.52 – 0.67, p < 0.01)
measures. The FR correlated significantly only with the severity (r = 0.45 – 0.69, p <
0.05) measures. The results indicated that the performance measures were more
sensitive to severity than disability. However, none of measures consistently
discriminated between levels of PD severity or disability. The investigators concluded
that assessment of interventions aimed at gait and balance are enhanced by assessing
functional measures including the SPPB, TUG, BBS and FR. In addition, the SPPB,
TUG and FR require only one to seven minutes to administer and are the best options
for busy clinical practices where time and ease of administration are critical8.
Factors associated with exercise behaviors in individuals with PD were examined
in a cross sectional study by Ellis et al11. There were 260 participants, age 40 years or
greater, classified at H&Y stage 1-4 and receiving pharmacological treatments in the
study. The Stages of Readiness to Exercise Questionnaire was used to designate
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participants as exercisers or non-exercisers. The Physical Activity Scale for the
Elderly (PASE) along with an activity monitor were used to validate exercise status.
The factors assessed included measures of body structure and function; activity;
participation; and environmental and personal factors. The measures used to quantify
factors associated with physical activity included the UPDRS (two groups - low
severity score <40; high severity score > 40), Geriatric Depression Scale (GPS), 6
minute walk test, Parkinson’s Disease Questionnaire-39 (participation), Self-Efficacy
for Exercise (SEE) and personal and environmental factors. Sixty three percent of the
participants were found to be exercisers. They had significantly lower UPDRS motor
scores (p < 0.02), less depression (p < 0.00), less restrictions in participation (p <
0.001), higher self efficacy (p < 0.001) and higher education (p < 0.00) than the nonexercisers. Self efficacy (p < 0.05) and education level (p < 0.05) were more strongly
associated with exercise behavior than disease severity, activity limitations or
restrictions in participation. Limitations of the study included using the selfadministered PASE to validate exercise behavior. The results suggested self efficacy
and the confidence to face barriers to exercise as a potential target for intervention11.
Individuals with PD may have difficulty walking outside the home environment
due to terrain characteristics, time constraints, walking distance and fluctuations in
impairment. Gait speed is one aspect of community walking and was compared with
demographic characteristics and clinical variables in a cross sectional study by Elbers
et al.12. The aim of the study was to examine if comfortable gait speed was a valid
measure to predict community walking in adults with PD on medication. Participants
were excluded if they undergone deep brain stimulation or experienced cognitive
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impairment. The cohort consisted of 153 participants with a mean age of 67 years (SD
7.54) diagnosed with PD. The evaluations were in the participants’ homes
approximately one hour after taking medications. The Nottingham Extended
Activities of Daily Index was used to identify community walkers. Seventy or 46
percent of the participants were classified as community walkers. Gait speed was
measured with the 10-m walk test repeated three times. A minimum distance of 6-m
was used to adapt to constraints in the participants’ homes. The time was converted to
m/s and the mean gait speed was 0.84 m/s (SD 0.20). The investigators established
0.88 seconds as a cut off value to discriminate between non-community and
community walkers. A receiver operating characteristic curve was constructed to
investigate the diagnostic accuracy of gait speed as a predictor for community walking
and showed that a cut-off point of 0.88 m/s correctly classified 70 percent of the
participants as community walkers and 72 percent as non-community walkers.
Multivariate regression analysis was also performed to evaluate the added value of
demographic and clinical variables in predicting community walking. Fear of falling
was found to have an added value in predicting community walking. Study limitations
included conducting the gait speed test in the participants’ homes and modifying the
distance from 6-10 meters. The results indicated that timed walking tests are valid
measures of community walking and that individuals who experience less fear of
falling are more likely to be community walkers12.
In summary, the articles reviewed provided study results concerning physical
performance measures, clinically important differences in gait speed, community
walking values and barriers to adopting physical activity among persons with PD.

37

Interventions assessing gait speed, where ease of administration and time are factors,
will be enhanced by using the SPPB, TUG and FR8. The clinically important
difference in gait speed ranged from 0.05 m/s to 0.22 m/s by distribution based
analysis and 0.02 m/s to 0.18 m/s by anchor based analysis10. Timed gait speeds tests
were reported to be valid measures to predict community walking and the
recommended cut-off value is 0.88 m/s12. Finally, self-efficacy and fear of falling are
behaviors that contribute to physical activity in individuals with PD11, 12. The data in
each of the studies was from a cross sectional cohort rather than a longitudinal
evaluation.

Acquired Brain Injury - Stroke
Acquired brain injury (ABI) is structural damage to the head after birth and
includes cerebrovascular accidents and TBI13. A cerebrovascular accident or stroke
occurs when a vessel in the brain is occluded or ruptures and is the fifth leading cause
of death and a leading cause of preventable disability in the United States (U.S.)14, 15.
An occluded vessel in brain results in an ischemic stroke whereas a blood vessel
rupturing results in a hemorrhagic stroke. Ischemic strokes account for 87 percent of
all strokes, and there is also a condition resulting from a temporary occlusion termed
transient ischemic attack (TIA) that produces stroke like symptoms but no lasting
damage14.
An estimated 6.8 million Americans over the age of 20 have experienced a stroke.
The overall prevalence is 2.8 percent for this population2. Over the past 10 years, the
actual number of stroke deaths declined by 21.2 percent, but approximately 795,000
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individuals continue to experience an ischemic or hemorrhagic stroke annually. The
decline in stroke mortality is attributed to the improvement in population health and
concurrent with the interventions to control cardiovascular risk factors. The
hypertension control efforts appear to have the most influence along with control of
diabetes mellitus and hyperlipidemia, and smoking cessation16.
The disease is seen primarily in adults over age 65, African Americans and
people living in the southeastern United States and is a major cause of long term
disability2, 13. African-Americans have nearly twice the risk for a first stroke than
Caucasians and a much higher death rate from stroke. This is attributed to the higher
risk of higher risk of high blood pressure, diabetes and obesity found in African
Americans. Females have more strokes than men with approximately 60 percent of
the stroke deaths occurring in women. Hormonal therapy used to prevent pregnancies
and increase estrogen levels in postmenopausal women, pregnancy, a history of
preeclampsia/eclampsia or gestational diabetes, and smoking increase the risks for
women. Heredity also plays a key role with stroke risk increasing if grandparents,
parents or siblings have experienced a stroke. Strokes may also be symptoms of
inherited genetic disorders including Cerebral Autosomal Dominate Arteriopathy with
Sub-Cortical Infarct and Leukoencephalopathy (CADASIL). Finally, individuals who
have experienced a stroke are at a higher risk for additional strokes14.
The primary risk factors for stroke include hypertension, diabetes mellitus,
hyperlipidemia, atrial fibrillation, smoking, heredity and physical inactivity2, 14. The
American Stroke Association has identified hypertension as the leading cause of
stroke and also described the following risk factors.
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 Diabetes mellitus is an independent risk factor and is also associated with high
blood pressure, hyperlipidemia and obesity.
 Hyperlipidemia can lead to atherosclerosis or the build-up of plaque in the
arteries resulting in narrowing of arterial walls and the risk for plaques breaking
open, bleeding and forming emboli.
 Atrial fibrillation can let blood pool and coagulate in the atrium and result in an
embolus raising the risk for a stroke.
 The nicotine and carbon monoxide associated with smoking cigarette damages
the cardiovascular system and leads to dyslipidemia, hypertension, damaged
endothelial cells, clotting of platelets and a decreased tolerance for exercise.
 Physical

inactivity can increase the risk for hypertension, diabetes, heart disease

and stroke14.
Stroke prevention involves managing the enabling factors listed above.
Pharmacological therapies may also be required to control and manage hypertension,
diabetes mellitus, hyperlipidemia and atrial fibrillation in high risk individuals.
Additionally, medical procedures including carotid endarterectomy may be required to
remove plaque from effected arteries14.
Immediate treatment may minimize the effects of ischemic strokes. The gold
standard for treatment is the FDA approved tissue plasminogen activator (tPA). This
thrombolytic treatment is delivered intravenously and works by dissolving the clot to
improve blood flow in the affected area of the brain. The individual’s chances for
recovery are improved if the medication is delivered within three hours and up to 4.5
hours for certain patients. Endovascular procedures and surgical treatments are used
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to treat hemorrhagic strokes. Endovascular procedures involve guiding a catheter
from a major artery in the arm or leg and inserting a device to prevent rupture of an
aneurysm or arteriovenous malformation (AVM). Surgical treatment may be required
to stop hemorrhage caused by ruptured aneurysm or AVM14.
The acute symptoms of stroke include face drooping or numbness, arm
hemiparesis, and speech difficulty. Other sudden symptoms include hemiparesis or
numbness of the leg, arm or face; confusion or trouble understanding; visual
disturbances in one or both eyes; trouble walking, dizziness, loss of balance or
coordination; and a severe headache with no known cause. Diagnosis is confirmed
through physical and neurological assessment and a computerized axial tomography
(CT) scan or magnetic resonance imaging (MRI) of the brain14.
Six months after stroke, nearly 50 percent of stroke survivors continue to
experience hemiparesis and cognitive linguistic deficits and thirty percent are unable
to walk without assistance2. Approximately, 12 to 43 percent of stroke survivors
experience further deterioration in mobility including walking speed and falls one to
three years after diagnosis. As a result, independent ambulation in the home or
community may be compromised. Factors affecting mobility are responsive to
modifications in physical activity; however, are scarcely described in the literature17.
A cross-sectional study by Vahlberg et al.17 examined the post stroke population
to assess mobility and physical activity and their relationship to physical,
psychological and demographic factors. The sample included 195 community-living
individuals age 65-85 years who had experienced a stroke in the last one to three
years. Mobility was measured using the SPPB and physical activity was assessed
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using the self-reported PASE. The performance based measures also included the
Berg Balance Scale and 10-m walking test. The mean SPPB score was 8.7 with a
standard deviation of 2.9. The mean comfortable gait speed for the 10-m walk test
was to found to be 1.10 m/s for the cohort and 1.16 m/s and 0.94 m/s for men and
women respectively. The results of both performance measures were found to be
below the results for a healthy population sample. The findings of the study reported
that performance based mobility was independently related to physical activity level,
fall related self efficacy and health-related quality of life. Likewise, physical activity
level was related to mobility, fall related self efficacy and health-related quality of life.
The investigators recommended future studies to evaluate the effect of actions to
improve mobility and fall-related self efficacy on physical activity levels in the poststroke population17.
Stookey et al.18 further analyzed the use the SPPB as a predictor of functional
capacity after stroke. Functional capacity was defined as those performance measures
that more closely mimic the endurance and distance requirements of community
ambulation. Forty three participants between the age of 43 and 87 were evaluated.
Each participant had completed conventional inpatient and outpatient physical therapy
and was six months post ischemic stroke or 12 months post hemorrhagic stroke. The
measures included the SPPB total score and component results (8 foot walk, standing
balance, chair stand); 6-minute walk; and VO2 Peak treadmill test (aerobic capacity).
Forty participants had a total SPPB scores of less than 10; an accepted threshold for
functional impairment. Thirty two participants scored one or zero on the chair stand
test. There was a significant correlation between the SPPB and the 6-minute walk (r =
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0.76, P < .001) and peak treadmill test (r = 0.52, p < .001). The 6-minute walk
relationship indicated that long distance walking capacity is captured by the SPPB.
The participants with higher SPPB scores were also found to walk a greater distance
the 6-m walk test. The study results indicated that the SPPB may be reflective of
endurance based, longer distance measures in chronic stroke patients18 although gait
tests that involve changes of direction may be more reflection of mobility and
community ambulation requirements.
The relationship between gait speed and community ambulation has been reported
in post-stroke individuals. Perry and al.19 tested 147 stroke patients that were at least
three months post stroke. The investigators assessed functional walking ability
through a walking ability questionnaire along with testing gait speed (10-m walk test),
muscle strength, proprioception. Gait speed was found to be the most efficient
predictor of household or community ambulation. Participants with an average speed
of 0.4 m/s were predicted to have the ability for community ambulation with the
highest category of community walking being 0.8 m/s19. Schmid et al.20 further
stratified gait speed into three classifications: household ambulation (<0.4 m/s),
limited community ambulation (0.4 to 0.8 m/s) and full community ambulation (>0.8
m/s). They studied 64 patients that were over 50 years old and 3-28 days post-stroke
to determine whether improvements in classification were related to clinically
meaningful changes in function and quality of life. The assessed gait speed using the
10-m walk test and function and quality of life using the Stroke Impact Scale (SIS).
Twelve of 19 household ambulators transitioned to limited community ambulation
whereas 17 of 45 limited community ambulators became full community ambulators.
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The function and quality of life SIS scores were significantly higher for the household
(p = 0.0299) and limited community (p = 0.0085) participants that advanced in
classification. The results supported the conclusion that a gain in gait speed that
results in a transition to a higher classification results in an improved function and
quality of life20.
A study of community ambulation conducted by van de Port et al.21, also
examined the association between gait speed and community ambulation and added
the effect of other confounding factors including age, living alone, history of falls,
assistive walking devices, executive function, depression, fatigue, motor function,
balance and walking endurance. Community ambulation was characterized by four
categories: inability to walk outside; ability to walk to the car or mailbox without
assistance; ability to walk in the immediate outdoor environment without assistance;
and ability to walk to stores, neighbors or activities without assistance. The sample
included 72 post stroke individuals with a mean age of 59 years. The data were
collected three years after the individual experienced the stroke. Gait speed was
measured in the participant’s home with the 5-m walking test. Seventy four percent of
the participants were identified as community walkers and 26 percent as non- or
limited community walkers. The average gait speed was 0.74 m/s (SD 0.30). The
optimal cut-off point for community ambulation of 0.66 m/s was determined using
receiver operation characteristic curve. Gait speed was found to be significantly
related to community ambulation and remained the significant determinant after the
confounders were added to the analysis. However, several factors were noted to
contribute to community walking ability including balance, motor function, endurance
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and use of assistive walking devices. Also, mobility is thought to be time-dependent
by the investigators and may decline over time21.
Schmid et al.22 studied individuals with chronic stroke to identify the mobility
impairment most associated with the individual’s activity in performance of tasks or
actions, and participation in life situations, i.e. returning to work. The cross-sectional
study sample consisted of 77 participants with an average age of 64 who were six
months post stroke. The outcome measures included gait speed (10-m walk) and
walking capacity (6-minute walk); balance (Berg Balance Scale); balance self-efficacy
(Activities-specific Balance Confidence); and falls self-efficacy (Modified Fall Self
Efficacy Scale). The gait speed for the 10-m walk was 1.33 m/s with a standard
deviation of 1.33, relatively high for individuals with chronic stroke. The study results
showed a stronger correlation between balance self efficacy and post-stroke activity
and participation (activity, r = -.544, p < .001; participation, r = -.459, p < .001; total
activity and participation, r = -.548, p <.001) than with the physical performance
measures of balance, gait speed and walking capacity. There was also strong
relationship between gait speed and activity (r = -.309, p = .006); however, gait speed
only weakly correlated with participation or total scores22.
A longitudinal study examining clinical determinants of deterioration in mobility
from one to three years post-stroke was also found in the literature. At one year poststroke, 264 participants aged 57 years (SD 11) were assessed. The sample decreased
to 205 participants at three years post-stroke with attrition attributed to withdrawals
from the study, death and individuals lost to follow up due to relocation. The
independent variables included patient and stroke characteristics, physical factors
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(Motricity Index), cognitive factors (mini mental state examination) and social factors
(Social Support List). The outcome variable, mobility, was assessed using the
Rivermead Mobility Index (RMI) that consists of 14 questions and one observation.
The RMI index score ranged from zero to 15 and a drop of > two points was
considered deterioration in mobility. Mobility decline was found in 21 percent of the
participants between one and three years (p < 0.05). Multivariate analysis showed that
level of activity, cognitive problems, fatigue and depression were statistically
significant predictors of mobility decline (Hosmer-Lemeshow test p > 0.05). The
results indicated that mobility decline is more strongly associated with psychological
and cognitive factors rather that physical factors. The investigators suggested that
early recognition and treatment of these risk factors may assist in preventing
deterioration of mobility status23.
Each of the cross sectional studies used gait speed as a measure of physical
function in the post stroke population. Gait speed was reported to be the most
efficient predictor of household and community ambulation, a significant determinant
of community ambulation, and a powerful indicator of function and prognosis poststroke19, 20, 21. An increase in gait speed was also reported to result in better function
and quality of life20. Gait speed was stratified into three community ambulation
classifications: household ambulation (<0.4 m/s), limited community ambulation (0.4
to 0.8 m/s) and full community ambulation (>0.8 m/s)19, 20. The optimal cut-off point
for community ambulation was later suggested to be 0.66 m/s21. The SPPB was found
to be reflective of endurance based, longer distance measures in chronic stroke
patients18 and related to physical activity level, fall related self efficacy and health-

46

related quality of life17. Balance self efficacy was a behavior also found to be strongly
correlated to post-stroke activity and participation17, 22. Finally, a longitudinal study
indicated that mobility decline is more strongly related with the presence of cognitive
problems, depression and fatigue rather than physical factors23.

Acquired Brain Injury – Traumatic Brain Injury
Traumatic brain injury is caused by an external blow or jolt to the head or an
object penetrating the skull that disrupts the normal function of the brain. A mild TBI
may cause a temporary dysfunction of the brain cells resulting in a brief loss of
consciousness or change in mental status. More severe injuries result in an extended
loss of consciousness, memory loss or death24, 25. The conditions caused by brain
injury can lead to physical, cognitive, and psychosocial issues and may cause
associated conditions including seizures, impaired reasoning, apraxia and aphasia13.
These individuals may also experience secondary sequelae including pain, depression,
fatigue, sedentary lifestyle and obesity13. An estimated 5.3 million Americans or two
percent of the population are living with a TBI related disability25.
Traumatic brain injury occurs most often within the age groups of 0-4 years, 1519 years, and over 65 years of age. Males are more likely to sustain a TBI in each of
the age groups. Falls are the leading cause of TBI and motor vehicle accidents are the
leading cause of TBI deaths1. Other leading causes of TBI include being struck by or
against events, assaults, and sports and recreation activities. Blasts are the leading
cause of TBI for military personnel assigned to war zones. Concussions and TBI
resulting from sports and recreation activities are severely underestimated. In a 2006
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overview article, Langlois et al.26 estimated that 1.6 million to 3.8 million sports
related TBIs occur each year. Their approximation includes those TBIs where no
medical care is sought and may be low since major injuries go unrecognized26.
Long term treatment includes inpatient and outpatient rehabilitation to improve
the individual’s ability to perform activities of daily living24. Eighty-three percent of
the individuals who suffer moderate to severe TBI will continue to demonstrate
deficits in balance and gait after returning home impacting their activities of daily
living and independence27.
A study done by Peters et al.27 assessed the impact of intensive mobility training
on balance, mobility and gait speed in individuals with chronic TBI. Ten individuals
aged 23.5 to 46 who were greater than three months post TBI participated in the study.
The training was held five days per week for four weeks. Each session lasted 150
minutes and involved task specific training equally divided among balance, gait
training, and strength and coordination. Minimal detectable changes along with
outcome measures including a 10-m walk test (gait speed) and TUG test (mobility)
were assessed. The MDC values for individuals with chronic stroke were substituted
for comparison because MDC is sparsely studied for the TBI population. Participants
demonstrated a significant change in walking speed and mobility at the 10 session
interim, 20 session post-test and 3 month follow up evaluations. At the interim, posttest and follow-up evaluations, participants also exceeded the MDC for the walking
speed test by 70, 80, and 60 percent respectively. There were smaller gains with the
TUG test with 50 percent exceeding the MDC for the TUG test at post-test and 20
percent exceeding at follow-up. Overall, the participants demonstrated improvements
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in walking speed, mobility and balance post-intervention. The gait speed and mobility
gains were also maintained at three months; however, no further evaluations were
performed27.
Several studies have suggested that postural instability contributes to slow gait
speed in TBI patients28. However, a study by Williams et al.29 found that postural
stability did not decrease with increasing gait speed and attributed reduced gait speed
to biomechanical deficiencies. In the study, individuals with TBI were assessed using
three dimensional gait analysis at self-selected (n=55) and fast walking (n=36) speeds
over a 12 meter walkway and compared to 10 healthy control (HC) individuals that
were speed matched to the mean TBI speeds. When compared to the HCs, the
individuals with TBI were found to walk with similar cadence (self-selected speed TBI 99.72 (14.61) step/min, HC 97.14 (3.27); fast speed - TBI 122.28 (15.61)
step/min, HC - 116.46 (5.68)) and step length (self-selected TBI - 0.61m (0.15) 0.64m (0.12), HC - 0.64m (0.03); fast speed TBI - 0.79m (0.13) – 0.82 (0.11), HC 0.80m (0.03)); however, their ankle power at push off was reduced (self-selected
speed - TBI 1.30 (0.72) W/kg, HC 1.75 (0.36); fast speed - TBI 1.91 (0.86) W/kg, HC
– 2.98 (0.32)) and hip power in early stance (self-selected speed - TBI 1.24 (0.72)
W/kg, HC 0.58 (0.12); fast speed - TBI 2.81 (1.73) W/kg, HC – 1.14 (0.18)) and
preswing (self-selected speed - TBI 0.92 (0.46) W/kg, HC 0.53 (0.12); fast speed TBI 1.55 (0.83) W/kg, HC – 1.03 (0.27)) was increased. They were also found to
have a significantly (p < 0.001) increased width of the base of support (self-selected
TBI - 0.24m (0.05), HC - 0.19m (0.02); fast speed TBI - 0.23m (0.05), HC - 0.19m
(0.02)) and postural instability (self-selected TBI - 89.06mm (31.52), HC – 53.40mm
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(7.06); fast speed TBI – 76.27mm (36.49), HC - 44.97mm (9.86)). The differences
between the groups remained constant at the fast speed and postural stability was
unchanged with increased gait speed; however, the gait tests were performed as
straight-line walking and no changes in direction were performed29.
Driver et al.30 studied barriers to physical activity in individuals with traumatic
brain injury. A convenience sample was used for the analysis and consisted of 28
participants aged 18 to 61 without significant cognitive impairment and enrolled in a
comprehensive outpatient program. A 16 item questionnaire was used to measure
demographics, physical activity participation, barriers to physical activity, perceived
importance of physical activity and stage of exercise change. Additional
questionnaires included the Behavioral Risk Factor Surveillance System (BRFSS),
Barriers to Physical Activity Scale for People with Physical Disabilities (B-PADS)
and Stages of Exercise Behavior Change. The participants reported zero to nine
barriers per individual with the female participants reporting more barriers than the
male participants. There were also differences in the barriers faced based on ethnicity
and race. The most frequently reported behaviors for the cohort included
environmental/facility and personal barriers. Lack of transportation and an accessible
facility were the most frequently reported environmental/facility barriers. Insufficient
endurance, feeling self-conscious in a fitness center and lack of time topped the
personal barrier list along with the participants’ disability preventing physical activity.
The investigators also noted that the participants reported facing fewer barriers than
reported in the literature for individuals with stroke. The participants may have
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perceived fewer barriers since they were only 57-90 days post injury and still involved
in a comprehensive outpatient program30.
In summary, gait speed was also used to assess physical function in individuals
with TBI. Postural stability was found to be stable with increasing gait speed and
reduced gait speed was attributed to biomechanical deficiencies29. Intensive mobility
training (IMT) was found to improve balance, mobility and gait speed in individuals
with chronic TBI. The gait speed and mobility gains were also maintained at three
months. The MDC values for individuals with chronic stroke were substituted for
comparison because MDC is sparsely studied for the TBI population27. Finally, the
barriers to physical activity most frequently reported by individuals with chronic TBI
include lack of transportation, lack of an accessible facility, insufficient endurance,
feeling self-conscious in a fitness center, lack of time along with the participants’
disability preventing physical activity30. Each of the studies used a cross sectional
design with exception of the study by Peters et al. Peters et al.27 used an experimental
design with a pre-test, interim test (10 sessions), post-test (20 session) and a three
month follow up evaluation27.

Conclusions
Individuals with chronic PD, TBI and stroke face declines in balance,
coordination, strength, mobility and overall quality of life. Gait speed, coined the
sixth vital sign, has been suggested to correlate with functional ability and balance
confidence and aids in determining rehabilitation potential and fall risk. Additionally,
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gait speed progression has been linked to improvement in quality of life and is critical
to maintaining community ambulation or independent mobility outside the home.
There is limited information in the literature about longitudinal changes in gait
speed in individuals who are in the chronic stages of Parkinson’s disease, stroke and
traumatic brain injury. There is even less information that jointly examines gait speed
in PD, stroke and TBI. The majority of studies reviewed measured gait speed using
cross sectional analysis. Research has yet to examine the long term status of physical
function and gait speed across the three chronic conditions.
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Appendix B: Extended Methodology
An individual’s ability to complete functional tasks can be predicted by
examining physical performance. Objective tests that evaluate performance include
the SPPB, gait speed and TUG test. The PADS provides a reliable and valid measure
of physical activity for persons with disabilities. Cognition has also been associated
with physical function and can be evaluated using the RBANS.
The SPPB was studied by Guralnik et al.1 and found to characterize older persons
across a wide variety of functional status and predict mortality and nursing home
admissions. The cohort for the study was part of the Established Populations for
Epidemiologic Studies of the Elderly (EPESE) and consisted of 5,000 adults aged 71
or older in three communities. The measures included using three activities to assess
the participant’s lower extremity functioning: standing balance, 8 foot gait speed and
repeated chair stands. The score range for each subtest was zero to four points with a
maximum cumulative score of 12 points. Self-reported physical functioning included
evaluating activities of daily living that required lower extremity function. The results
of the study revealed that performance on each of the tests were strongly associated
with self-reported disability and predictive of mortality and nursing home admissions1.
Lower extremity function is thought to be predictive of disability because it reflects
the effects of chronic disease, comorbidities, and physiological decline that are yet to
cause obvious disability. A subsequent study by Guralnik et al.2 reported that
participants with performance scores of less than 10 are more likely to have a
disability in activities of daily living or a mobility related disability2.
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Kwon et al.3 analyzed data from the Lifestyle Interventions and Independence for
Elders Pilot Study (LIFE-P) to determine the magnitude of meaningful change in the
SPPB, 4-m gait speed and 400-m walk test. The participants were 424 sedentary
adults aged 70-80 who scored less than 10 on the SPPB and were able to complete a
400-m walk test in 15 minutes or less. The individuals were also participating in a
structured physical activity intervention of the LIFE-P study. Participants who
reported no difficulty or could not perform the activities were excluded from the
study. The investigators applied anchored and distribution based methods for selfreported mobility to estimate minimal and substantial change in the performances
measures over one year. Self-reported mobility status was gathered using a Disability
Questionnaire and provided the anchor measures. The distribution based analysis used
the effect size method and standard error of the measurement. The study reported the
best estimates for a minimally meaningful change for the SPPB total score to be 0.3 to
0.8 points, 0.03 to 0.05 m/s for the 4-m gait speed, and 20 to 30 seconds for the 400-m
walk test. A range of 0.4 to 1.5 points for the SPPB, 0.08 for the 4-m gait speed, and
50 to 60 seconds for the 400-m walk test were reported as substantial change. The
longitudinal format of the study was reported as a strength along with the LIFE-P
study’s intervention increasing the participants’ potential to improve performance.
The study limitations included the self-reported anchor measures and missing data at
the 12-month evaluation. The study concluded that clinically important changes in
performance measures were consistent using several analytical techniques and the
changes appear to be attainable in clinical trials of exercise3.
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Gait speed alone has been suggested to correlate with functional ability and
balance confidence and aids in determining rehabilitation potential and fall risk4.
Additionally, gait speed progression has been linked to improvement in quality of life4,
5

. Coined the sixth vital sign, gait speed can provide a functional perspective to health

status similar to temperature, pulse, respirations, blood pressure and pain4. Gait speed
has also been identified as an important concern when determining the ability to
ambulate outside of the home (or ambulate in the community) and distinguishing
between limited and full community ambulation. Examples of gait speed
recommendations in the community include the requirement to safely cross
intersections and crosswalks. Andrews et al.6 studied these requirements along with
the distance requirements for community ambulation. Distances were measured from
and to the closest handicapped parking place to the closest entrance and within the
facilities at nine types of sites including supermarkets, drug stores, banks, department
stores, post offices, medical offices, superstores, club warehouses and hardware stores.
A total of 141 establishments in 15 cities were measured and the distances ranged
from 52 m to 676.8 meters with the shortest distances found at post offices, banks and
medical offices. The longest distances were found at hardware, superstore and club
warehouses where power scooters were available. Crosswalk distances were measured
in four cities curb to curb for two to six lane crosswalks. The time allotted to walk
was recorded from the beginning of the “walk” signal to the “don’t walk” signal. The
time required to walk was also measured for 128 individuals (n = 32 > 65 years, n =
96 < 65 years) crossing the intersection. The mean gait speed used by the individuals
was 1.32 (SD 0.31) m/s. The mean speed required as set by the signals was 0.49 (SD
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0.20) m/s. The results of the study suggested that 600 m or more may be distance
requirement for full community ambulation and found that speed requirements were
set to accommodate the gait speed of older adults6.
A study by Duff et al.7 reported that global cognition was related to gait speed in
older adults with slower walkers performing worse on the cognitive measures and
faster walkers performing better. The study was part of the Oklahoma Longitudinal
Assessment of Health Outcomes in Mature Adults (OKLAHOMA) Studies and the
sample consisted of 675 community dwelling older adults aged 65 and older.
Individuals were excluded from the study if they were unable to perform the gait
speed test or had comorbidities that would impact cognitive functioning or gait speed
including stroke or TIA, head injury or concussion, seizures, PD or brain hemorrhage.
The investigators hypothesized that global cognition would be related to gait speed
along with other cognitive domains. Global cognition was assessed using the
Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) total
scale score7. The RBANS consists of 12 subtests and is also used to measure
immediate and delayed memory along with language, attention and visuospatial/
constructional abilities. The delayed memory index includes four subsets (list recall,
list recognition, story recall, and figure recall) that measure recall and recognition.
The results can be used to assess cognitive function in individuals from 20-89 years in
age8. The index score results were total scale 98.2 (SD 16.1), immediate memory 95.4
(SD 18.0), language 95.6 (SD 11.4), attention 100.2 (SD 16.1),
visuospatial/constructional 102.9 (SD 17.7), and delayed memory 98.8 (SD 17.1).
Gait speed was measured using a 50-foot course. Participants were asked to walk 25
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feet and return at their usual walking speed. The cohort was divided into three groups
based on gait speeds of <14 seconds, 14-17 seconds, and >17 seconds. There were
significant differences between the groups on age, gender and education. Partial
correlations, controlling for age, gender, and education, identified statistically
significant relationships (p < .01) between gait times and the RBANS total and each of
the component indexes7.
The TUG test is a valid predictor of falls and mobility and measures the time in
seconds required for an individual to rise from a chair, walk three meters, return and
sit down in the chair9. Whitney et al.9 studied how the TUG test could be used in
association with the Physiological Profile Assessment (PPA) to identify individuals at
high risk for falls. The sample consisted of 110 adults aged 63-95 years of age who
had fallen in the preceding 6-8 weeks. Fall risk was determined using the PPA and the
participants were divided in to low and high fall risk groups based on the score. An
Abbreviated Mental Test (AMT) was also administered to evaluate cognitive
impairment. The study findings suggested that the TUG test and AMT scores were
predictive of high fall risk. The optimal cut-point for differentiating between high and
low fall risk of 15 seconds was determined using ROC analysis9.
The PADS provides a reliable and valid measure of physical activity for persons
with disabilities or chronic health conditions and has been reported to detect
intervention related changes in physical activity10. Rimmer et al. examined the
psychometric properties of the PADS. The study sample consisted of 103 adults aged
30-70 years with disabilities and chronic health conditions. The measures were 46
items in three subscales: exercise, leisure time physical activity and household
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activity. The fitness measures included a graded exercise test and anthropometric
measures. The findings supported the internal consistency, reliability and ability of
PADS to detect intervention related changes in physical activity indicating that the
instrument is useful for monitoring baseline levels and changes in physical activity
among persons with disabilities and chronic health conditions10.
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Appendix C: Consent Form for Research
Longitudinal Study of Communication, Nutrition and Physical Activity
Leslie A. Mahler, PhD, Principal Investigator
Ingrid Lofgren, PhD, co-Investigator
Matthew Delmonico, PhD, co-Investigator
CONSENT FORM FOR RESEARCH: Participant
Version 3: April 4, 2014
The University of Rhode Island
Department of Communicative Disorders
25 W Independence Square, Suite I
Kingston, RI 02881
Purpose of the Consent:
You have been invited to take part in a research project described below. The purpose
of the consent form you are about to read is to provide you with details about the
research study and to inform you of your rights if you agree to participate in the study.
Your participation is completely up to you. The researcher will explain the project to
you in detail. You should feel free to ask questions. If you have more questions later
you can call, Dr. Leslie Mahler, the person mainly responsible for this study, at 401874-2490. You may also contact Dr. Ingrid Lofgren at 401-874-5706 or Dr. Matthew
Delmonico at 401-874-5440, who are co-Investigators on the study. You must be at
least 18 years old, speak English, and have neurological diagnosis of traumatic brain
injury, stroke, or Parkinson disease to be in this research project.
Description of the project:
This is a research project designed to look at communication, nutrition, and physical
activity characteristics of adults who have a stroke, traumatic brain injury or Parkinson
disease. All evaluations will be conducted at one of two University of Rhode Island
locations; in Independence Square on the Kingston Campus at 25 West Independence
Way, Kingston or in Independence Square at 500 Prospect Street in Pawtucket.
You are being asked to be in this study because we want to determine the long-term
impact of neurological disorders on communication, nutrition, and physical activity.
We are looking for 200 people who have a stroke, traumatic brain injury or Parkinson
disease to participate in this project. Participation in this study is entirely your choice.
If you decide to take part in this study, you should understand that the evaluations are
investigational and you may not experience any benefit from participation.
Participation may also involve additional risks as listed in the Potential Risks and
Discomforts section. The consent form will help make sure you understand the tasks
included in the study before you decide whether you want to take part in the study.
You may also quit the study at any time.
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What will be done:
If you agree to take part in this study, you will be asked to complete up to 11
evaluations over five years. Evaluations will take place every six months. The
evaluations will include a variety of tasks such as reading sentences and describing a
picture, an assessment of how your muscles move, a cognitive screening, an interview,
a clinical swallowing evaluation, and questionnaires regarding swallowing, diet and
physical activity. The total time for each evaluation will be approximately 3½ hours.
All evaluations will be conducted in a quiet private room at one of the University of
Rhode Island Speech and Hearing Clinic locations (Kingston or Pawtucket).
With your permission, we will request health information from your physician about
the following specific items only:

 Date of diagnosis
 Current medications
 Imaging information about where the brain damage is located (if
appropriate)
 Stage of Parkinson disease (if applicable)
You will sign a separate form to indicate whether you give your permission to
release this health information for the study.
Potential risks and discomforts:
There are minimal foreseeable risks associated with these evaluations. There have
been no reported adverse affects from clinical evaluation of speech and swallowing.
There may be some unknown or unanticipated risks, but every precaution will be
taken to ensure your personal safety. Even though experienced personnel will obtain
the blood samples from a finger prick, there is a chance of discomfort and minor
bruising from the finger stick. For physical function testing there is a risk of muscle
soreness or other muscle injury as well as skeletal injury but we will minimize these
risks by using standard safety practices.
Purpose and benefits of the study:
The purpose of this study is to describe communication, nutrition, and physical
activity behaviors over time to see how they change and affect quality of life. The
information obtained is important because it will help us to understand how to provide
services to meet the needs of people with neurological diagnoses. This is an
investigational study and there is no guaranteed benefit to your communication or
nutrition or physical function as a result of participation in this research study. You
will receive personal health information such as your height and weight, physical
function determined by a physical assessment, your blood lipids such as cholesterol
and triglycerides. In addition, you will receive information about your thinking skills
and language skills and dietary choices.
Drugs, devices or instruments to be used:
Drugs will not be used in this study. The equipment for the evaluations include:
microphone, sound level meter, tongue blade, a digital tuner, tape recorder, and video
cameras. All equipment used to collect cognitive-linguistic and physical function data
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is considered non-invasive. A lancet and capillary tube will be used to obtain the blood
sample from a finger prick and the sample will be analyzed on a small portable
machine that is on a table.
Cost to participant:
There is no cost to you for participation in the evaluations. Parking is available for
free.
Confidentiality:
Your part in this study is confidential. Your individual privacy will be maintained in
all published and written data resulting from this study. No names of participants will
be published or included in written data resulting from this study. Results of this
study may be used for purposes of research, educational lectures, and/or professional
presentations. When you are entered into the study you will be assigned a code that
does not include any identifying information. For example, the first participant will be
coded as Long01. The code number will be used on all response forms and in the
analysis of the data.
Dr. Mahler and her research team will have sole access to all contact information and
evaluation results containing your name. This information will be kept in a locked
filing cabinet in a locked office. However, the U.S. Department of Health and Human
Services, and the University of Rhode Island Institutional Review Board have the right
to inspect all of your records relating to this research for the purpose of verifying data.
Because of the need to release information to these parties, absolute confidentiality
cannot be guaranteed. Following completion of this project, contact information will
be destroyed for those participants who wish, for any reason, not to be contacted in the
future. All other information will be archived and kept in a locked filing cabinet with
the study results at the University of Rhode Island. All research data will be retained
for a minimum of three years following completion of the study and then will be
destroyed. Research data will be located in a locked filing cabinet in the principal
investigator’s locked office.
Cognitive-linguistic evaluations will be audio and video recorded to allow for data
analyses. At times these recordings can be useful for teaching students or
professionals about the disorders of people with a neurological diagnosis such as
yours. Please indicate by signing below whether you give your permission to use your
samples for lectures and presentations. Audio and/or videotapes may be used for
teaching for up to 3 years after completion of the study. If you agree, you will never
be identified by name in the presentations or lectures. Your decision to give
permission to use audio and/or video samples in lectures has no impact on your
participation in the study.
__________Yes, I give permission to use audio samples in lectures and presentations.
__________Yes, I give permission to use video samples in lectures and presentations.
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__________No, I do not want audio samples used except for research analysis.

_____________No, I do not want video samples used except for research analysis.
In case there is any injury to you during the study:
If this study causes you any injury, you should immediately contact Dr. Leslie Mahler
at (401) 874-2490 or contact the University of Rhode Island Speech and Hearing
Clinic at (401) 874-5969. You may also call the office of the Vice President for
Research Integrity, 70 Lower College Road, University of Rhode Island, Kingston, RI
at (401) 874-4328. If you are injured during an evaluation or during treatment every
effort will be made to get you medical attention but you will be responsible for paying
for the medical treatment needed.
Decision to quit at any time:
The decision to take part in this study is up to you. You do not have to participate. If
you decide to take part in the study, you may quit and stop participating in this study
at any time. You have the right to refuse to answer any question(s) or participate in
any procedure for any reason. Deciding not to participate will have no effect on your
potential to receive services from a speech-language pathologist. If you wish to quit,
simply inform Leslie Mahler at 874-2490 of your decision. If you wish to pursue an
alternative treatment instead of completing the study you will be provided with
information on how to obtain those services.
Rights and complaints:
If you are not satisfied with the way this study is performed, you may discuss your
complaints with Dr. Leslie Mahler (lmahler@uri.edu; 401-874-2490), Dr. Ingrid
Lofgren (ingridlofgren@uri.edu, 401-874-5706), or Dr. Matthew Delmonico
(delmonico@uri.edu; 401-874-5440), or you may contact the office of the Vice
President for Research for concerns or any questions about your rights as a research
subject at: 70 Lower College Road, University of Rhode Island, Kingston, RI at (401)
874-4328 and speak to them anonymously if you choose.
Authorization:
Your authorization means that you have read this paper and know the purpose of the
study and the possible risks and benefits. It also means you know that being in this
study is voluntary and you choose to be in this study. You can also withdraw at any
time. Your questions have been answered. Your signature on this form means that
you understand the information and you agree to participate in this study.
________________________ ________________________
Signature of Participant Signature of Researcher

_________________________ ________________________
Participant Typed/printed Name Researcher Typed/printed name
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__________________________ _______________________
Date
Date

________________________ ________________________
Signature of Guardian
Signature of Researcher

_________________________ ________________________
Guardian Typed/printed Name Researcher Typed/printed name

__________________________ _______________________
Date
Date
Please sign both consent forms, keeping one for yourself.
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Appendix D: Short Physical Performance Battery (SPPB)
SPPB
BALANCE SCORING:
A. Side-by-side-stand
Held for 10 sec ❒ 1 point
Not held for 10 sec ❒ 0 points
Number of seconds held if less than 10 sec: ____sec
Not attempted ❒ 0 points
If participant did not attempt test or failed, check why:
Participant could not walk unassisted ❒
Not attempted, you felt unsafe ❒
Not attempted, participant felt unsafe❒
Participant unable to understand instructions ❒
Other (Specify) ❒
Participant refused ❒
If 0 points, end Balance Tests
B. Semi-Tandem Stand
Held for 10 sec ❒ 1 point
Not held for 10 sec ❒ 0 points
Number of seconds held if less than 10 sec: ____sec
Not attempted ❒ 0 points
If participant did not attempt test or failed, check why:
Participant could not walk unassisted ❒
Not attempted, you felt unsafe ❒
Not attempted, participant felt unsafe❒
Participant unable to understand instructions ❒
Other (Specify) ❒
Participant refused ❒
If 0 points, end Balance Tests
C. Tandem Stand
Held for 10 sec ❒ 2 points
Held for 3 to 9.99 sec ❒ 1 point
Held for < than 3 sec ❒ 0 points
Not attempted ❒ 0 points
If participant did not attempt test or failed, check why:
Participant could not walk unassisted ❒
Not attempted, you felt unsafe ❒
Not attempted, participant felt unsafe❒
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Participant unable to understand instructions ❒
Other (Specify) ❒
Participant refused ❒
D. Total Balance Tests score ______ (sum points)
Comments:
GAIT SPEED TEST SCORING:
Length of walk test course: Four meters
A. Time for First Gait Speed Test (sec)
Time for 4 meters ____sec
If participant did not attempt test or failed, check why:
Tried but unable ❒
Participant could not walk unassisted ❒
Not attempted, you felt unsafe ❒
Not attempted, participant felt unsafe❒
Participant unable to understand instructions ❒
Other (Specify) ❒
Participant refused ❒
Aids for first walk……………None ❒Cane ❒ Other ❒
B. Time for Second Gait Speed Test
1. Time for 4 meters ____sec
2. If participant did not attempt test or failed, check why:
Tried but unable ❒
Participant could not walk unassisted ❒
Not attempted, you felt unsafe ❒
Not attempted, participant felt unsafe❒
Participant unable to understand instructions ❒
Other (Specify) ❒
Participant refused ❒
Aids for second walk………… None ❒ Cane ❒ Other ❒
What is the time for the faster of the two walks? ________sec.
If the participant was unable to do the walk: ❒ 0 points
For 4-Meter Walk:
If time is more than 8.70 sec: ❒ 1 point
If time is 6.21 to 8.70 sec: ❒ 2 points
If time is 4.82 to 6.20 sec: ❒ 3 points
If time is less than 4.82 sec: ❒ 4 points
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CHAIR SCORING:
Single Chair Stand Test:
Safe to stand without help YES ❒ NO ❒
Participant stood without using arms YES ❒ NO ❒ If yes go to repeated stand
Participant used arms to stand YES ❒ NO ❒ If yes end test; score as 0 points
Test not completed ❒ End test; score as 0 points
If participant did not attempt test or failed, check why:
Tried but unable ❒
Participant could not walk unassisted ❒
Not attempted, you felt unsafe ❒
Not attempted, participant felt unsafe❒
Participant unable to understand instructions ❒
Other (Specify) ❒
Participant refused ❒
Repeated Chair Stand Test
Safe to stand five times Yes❒ No❒ If five stands completed record time
Time to complete five stands ___sec
If participant did not attempt test or failed, circle why:
Tried but unable ❒
Participant could not walk unassisted ❒
Not attempted, you felt unsafe ❒
Not attempted, participant felt unsafe❒
Participant unable to understand instructions❒
Other (Specify) ❒
Participant refused ❒
Scoring the Repeated Chair Test
Participant unable to complete 5 chair stands or completes stands in >60 sec: ❒ 0
points
If chair stand time is 16.70 sec or more: ❒ 1 points
If chair stand time is 13.70 to 16.69 sec: ❒ 2 points
If chair stand time is 11.20 to 13.69 sec: ❒ 3 points
If chair stand time is 11.19 sec or less: ❒ 4 points
Scoring for Complete Short Physical Performance Battery
Total Balance Test score _____ points
Gait Speed Test score _____ points
Chair Stand Test score _____ points
Total Score _____ points (sum of points above)
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Appendix E: Timed Up and Go (TUG) Test

TIMED UP AND GO
Time for first TUG test (sec)
Time: ______sec
If participant did not attempt test of failed, check why?
Tried but unable___
Participant could not walk unassisted____
Not attempted, you felt unsafe____
Not attempted, participant felt unsafe____
Participant unable to understand instructions_____
Other (specify) _____
Participant refused______
Aids for first walk………….None____ Cane_____ Other_____
Time for second TUG test (sec)
Time: ______sec
If participant did not attempt test of failed, check why?
Tried but unable___
Participant could not walk unassisted____
Not attempted, you felt unsafe____
Not attempted, participant felt unsafe____
Participant unable to understand instructions_____
Other (specify) _____
Participant refused______
Aids for second walk………….None____ Cane____
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Physical Activity and Disability Scale
DEMOGRAPHICS
NAME:______________________________ DATE: ______________
AGE:

______ years

GENDER
Male
Female
TYPE OF DISABILITY ____________________________________
ASSISTIVE DEVICES (Check all that apply)
Walker
Braces
Cane
Wheelchair
USE OF ARMS (Check one)
Full
Partial
No Use
USE OF LEGS
Full
Partial
No Use
Directions: On the following pages are a list of questions related to physical activity and
exercise. There are no right or wrong answers and your responses will be kept anonymous.
Note that your answers to certain questions in the survey may cause your browser to skip
other questions and move to a later item in the survey. Don't worry--this is how the survey was
designed in order to save time. Please answer each presented question as accurately and as
completely as possible. When you have finished the survey, press the "Submit" button. Your
survey responses will be checked and used to create scores reflecting your level of physical
activity. A window presenting your scores will then appear.
Page 1 of 8
PADS Questionnaire 01.18.2006
revised 1/11/2006

Physical Activity and Disability Scale
1.

EXERCISE

1.00

Do you currently exercise?
Yes
No

IF NO, PLEASE GO TO THE LEISURE ACTIVITY SECTION.
1.01

What kind of exercise do you do?
Directions: List up to four (4) activities below that you do on a regular basis for primary
purpose of increasing or maintaining fitness. Aerobics are done for a sustained period of
time and result in an increase in your heart rate and breathing rate. Examples include
walking, jogging, attending an aerobics class, and bicycling. Strength activities include
lifting weights or using elastic bands or weight training machines. Flexibility refers to
activities that involve muscle stretching
Activity Type
Code:
A:
S:
F:
Activity Type
(check one)

1.02

A

S

F

A

S

F

A

S

F

A

S

F

Activity

Description
Aerobic Exercise
Strength Exercise
Flexibility Exercise

Days/Week

Minutes/Day Months/Year

Have you been exercising for more than one year or less than one year?
More than one year
Less than one year

1.03

How would you describe the average intensity of your exercise program?
Light exercise: Don’t sweat or breathe heavily
Moderate exercise: Breathe a little harder and may sweat
Vigorous: Breathe hard and sweat
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revised 1/11/2006

Physical Activity and Disability Scale
2.
2.0

LEISURE ACTIVITY
Do you engage in leisure time physical activity?
Yes
No

IF NO, GO TO THE GENERAL ACTIVITY SECTION ON THE
NEXT PAGE.
2.1

What type of activities do you do?
Directions: List up to four (4) activities below that you do for leisure or recreation.
These activities can be done on a regular or irregular basis and may not necessarily
result in sustained increases in heart rate and breathing rate. Examples include hiking,
boating, skiing, dancing and sports activities. Please indicate whether the activity is an
endurance activity or a Non-Endurance activity. Examples of endurance activities
include: hiking, tennis, dancing, skiing. Non-endurance activities include boating,
softball and horseback riding. Do not list activities here that you already listed under
exercise.
Activity Type
Code
E
NE

Activity Type
(check one)
E

NE

E

NE

E

NE

E

NE

Description
Endurance
Non-Endurance

Activity

Days/Week

Minutes/Day

Months/Year
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Physical Activity and Disability Scale
3.
3.00

GENERAL ACTIVITY
From Monday through Friday, how many waking hours a
day do you usually spend inside your home?
Less than 6 hours a day
6 to 10 hours a day
More than 10 hours a day

3.01

On Saturday and Sunday, how many waking hours a day do
you usually spend inside your home?
Less than 6 hours a day
6 to 10 hours a day
More than 10 hours a day

3.02

On average, how many hours a day do you sleep including
naps?
________________ hours

3.03

On average, how many hours a day are you sitting or lying
down, excluding sleeping?
________________ hours

3.04

Are most of your indoor household activities done by you
or someone Else?
Done by you
Done by someone else

IF DONE BY SOMEONE ELSE, GO TO QUESTION 3.06.
3.05

Please list up to four (4) indoor household activities you do
and the number of minutes a week you spend on each
activity.
Activity

Minutes/Week
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Physical Activity and Disability Scale

3.06

Do you do any outdoor household activities such as
gardening?
Yes
No

IF NO, GO TO QUESTION 3.08.
3.07

Please list up to four (4) outdoor household activities you
do and the number of minutes a week you spend on each
activity.
Activity

3.08

Days/Week

Minutes/Day

Months/Year

How much assistance do you need to perform activities of
daily living such as dressing and bathing?
No assistance
Some assistance
Full assistance
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Physical Activity and Disability Scale
4.
4.00

THERAPY
Do you currently receive physical or occupational therapy?
Yes
No

IF NO, GO TO EMPLOYMENT SECTION ON THE NEXT
PAGE.
4.01

How many days a week do you receive therapy?
_________ Days.

4.02

How long does each therapy session usually last?
__________ Minutes
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Physical Activity and Disability Scale
5.
5.00

EMPLOYMENT / SCHOOL
Are you currently employed / attending school?
Employed
Not employed

Retired
Attending school

IF UNEMPLOYED OR RETIRED, GO TO WHEELCHAIR
SECTION ON THE NEXT PAGE.
5.01

For most of your work / school day, do you:
Move around
Stand
Sit

5.02

Do you climb any stairs during the work / school day?
Yes
No

IF NO, GO TO QUESTION 5.04.
5.02a How many flights of stairs do you climb? ___________ flights
5.02b How many times a day do you climb the stairs? __________
5.03

In your transportation to and from work / school, do you get
any physical activity?
Yes
No

IF NO PLEASE GO TO WHEELCHAIR SECTION ON THE
NEXT PAGE.
5.04

Please list up to four (4) employment-related physical
activities you do and the number of minutes a week you
spend on each activity.
Activity

Days/Week

Minutes/Day

Months/year
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Physical Activity and Disability Scale
6.
6.00

WHEELCHAIR USERS
Do you use a wheelchair?
Yes
No

IF NO, STOP HERE.
6.01

How many years have you used a wheelchair? ______ years?

6.02

During the time that you are awake, how much time do you:
spend in your wheelchair?
All day
Most of the day
A few hours

6.03

What type of wheelchair do you primarily use?
Manual wheelchair
Powered wheelchair

IF POWERED WHEELCHAIR, STOP HERE.
6.04

Who usually pushes your wheelchair?
Myself
Someone else

IF SOMEONE ELSE, STOP HERE.
6.05

On average, how many minutes a day do you push yourself
in your wheelchair?
Less than 60 minutes
Sixty minutes or more

Thank you for completing this survey!
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